Ion Beam ApplicationsIOBCF +2.18%82 PB Ratio is 3.73 as of Jun. 25, 2026, which is 2% above its 10-year median of 3.67. GuruFocus rates IOBCF with a GF Score™ of 82/100 and a GF Value™ of $18.71 (Fairly Valued). The stock has 10 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Ion Beam Applications ranks worse than 72.72% on this metric.
Ion Beam Applications SA stock PB Ratio (=3.8) is close to 3-year high of 4.12.
The historical rank and industry rank for Ion Beam Applications's PB Ratio or its related term are showing as below:
IOBCF'
s PB Ratio Range Over the Past 10 Years
Min: 1.85 Med: 3.67 Max: 11.14
Current: 3.72
During the past 13 years, Ion Beam Applications's highest PB Ratio was 11.14. The lowest was 1.85. And the median was 3.67.
IOBCF's PB Ratio is ranked worse than 72.72% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.045
vs IOBCF: 3.72
During the past 12 months, Ion Beam Applications's average Book Value Per Share Growth Rate was 14.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -2.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -1.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Ion Beam Applications was 39.10% per year. The lowest was -26.90% per year. And the median was -0.60% per year.
Back to Basics: PB Ratio
Ion Beam Applications (OTCPK:IOBCF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Ion Beam Applications's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ion Beam Applications PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's PB Ratio distribution charts can be found below:
* The bar in red indicates where Ion Beam Applications's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Ion Beam Applications (IOBCF) has a PB Ratio of 3.73 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Ion Beam Applications and its competitors. This is near median its historical median of 3.67. Over the past decade, Ion Beam Applications' PB Ratio has ranged from 1.85 to 11.14. According to the industry distribution chart, Ion Beam Applications ranks #573 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 72.7%.
Is Ion Beam Applications' PB Ratio too high?
Ion Beam Applications' current PB Ratio of 3.73 is near median its 10-year median of 3.67. Over the past 10 years, this metric has ranged from a low of 1.85 to a high of 11.14. The Medical Devices & Instruments industry median PB Ratio is 2.05. Ion Beam Applications' value of 3.73 is 82.4% above this industry median. Based on the distribution chart, Ion Beam Applications ranks #573 out of 788 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ion Beam Applications has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #573 out of 788 companies for PB Ratio. This places Ion Beam Applications in the lower half of its industry. The industry median PB Ratio is 2.05. Ion Beam Applications' value of 3.73 is 82.4% above this benchmark. Historically, Ion Beam Applications' own PB Ratio has ranged from 1.85 to 11.14 over the past decade. While the company's 10-year median is 3.67 vs. the industry median of 2.05, Ion Beam Applications has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ion Beam Applications's current PB Ratio of 3.73 is 82.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Ion Beam Applications and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ion Beam Applications's current PB Ratio is 3.73, which is near median its own 10-year median of 3.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (IOBCF) is currently considered Fairly Valued. The stock's GF Value™ is $18.71, compared to a current price of $18.90 — trading 1% above its estimated fair value. The current PB Ratio is 3.73, which is near median its 10-year median of 3.67 and 82.4% above the Medical Devices & Instruments industry median of 2.05. Ion Beam Applications' overall GF Score™ is 82/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Ion Beam Applications (IOBCF), the current PB Ratio is 3.73 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ion Beam Applications (IOBCF) Overvalued in 2026?
Based on GuruFocus' analysis, Ion Beam Applications stock appears to be overvalued.
The current stock price of $18.90 is trading 1% above its estimated GF Value™ of $18.71.
GuruFocus considers Ion Beam Applications to be Fairly Valued.
Key valuation signals for IOBCF:
PB Ratio: 3.73 (near median its 10-year median of 3.67)
GF Value™: $18.71 vs. price of $18.90 (1% above fair value)
Industry Position: 82.4% above the Medical Devices & Instruments median (#573 of 788)
No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
82GF Score
Get the complete analysis for IOBCF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOBCF has been successfully added to your 
